Close Menu

NEW YORK – Boston-based NanoView Biosciences has signed an exclusive agreement with Isaza Scientific to distribute Nanoview's ExoView platform in Spain and Portugal.

The research-use-only ExoView platform is an antibody labeling and imaging-based extracellular vesicle detection tool that provides high-resolution sizing, counting, and phenotyping. NanoView said that the platform requires minimal sample input, no sample prep or purification, and can be used directly with complex biological samples.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A German shepherd called Nala has had her genome sequenced.

A coronavirus serology test garners Emergency Use Authorization from the US Food and Drug Administration, but the Los Angeles Times asks: how will tests like that be used?

Certain gene variants in conjunction with a healthy lifestyle may keep brains young, according to New Scientist.

In Science this week: increased CD8 T cell density and increased IFN-gamma response may indicate metastatic prostate cancer patients who will respond to immune checkpoint blockade therapy.